March 9, 2018
UNC Lineberger's Barbara Alvarez Martin, MPH, was honored for her work bringing together organizations to improve the health and well-being of Triangle-area communities and residents.
February 22, 2018
The lab of Zhen Gu, PhD, in the joint UNC-NC State biomedical engineering department developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumor site.
February 5, 2018
In a study led by UNC Lineberger's Adam Goldstein, MD, researchers found that efforts are needed to help youth remain nicotine free – especially those adolescents who aren’t otherwise susceptible to smoking cigarettes.
January 16, 2018
To improve treatment and our understanding of one of the deadliest cancers in the United States, UNC Lineberger's Jen Jen Yeh, MD, was involved in two studies that take different approaches to precision medicine for pancreatic cancer.
January 12, 2018
Donald Rosenstein, MD, and Justin Yopp, PhD, have published a compelling book, “The Group: Seven Widowed Fathers Reimagine Life,” that recounts the lessons a group of widowed fathers learned in responding to loss and grief.
May 9, 2017
UNC's Running RAScals participated in this year’s PanCAN PurpleStride run. The team, organized by Kirsten Bryant, PhD, consisted of 76 members and raised over $13,000 to support the Pancreatic Cancer Action Network.
March 13, 2017
UNC Lineberger's Shelton Earp, MD, director of UNC Cancer Care and the Lineberger Professor of Cancer Research, and Jenny P.Y. Ting, PhD, the William Rand Kenan Professor of Genetics, have been honored with the Hyman L. Battle Distinguished Cancer Research Award.
January 22, 2017
August 8, 2016
UNC Lineberger researcher and postdoctoral fellow Kirsten Bryant, PhD, has been awarded a prestigious grant by the American Association for Cancer Research and the Pancreatic Cancer Action Network.
May 9, 2016
In the lab of Channing Der, PhD, researchers believe they have found a promising strategy to target a type of pancreatic cancer that is notoriously resistant to treatment—pancreatic cancer that has a mutation in a gene called KRAS.
